Subscribe To
Cti biopharma skyrockets on acquisition by sobi
CTI BioPharma shares added almost 85% on the news that the company would be acquired by Stockholm-based hematology and immunology leader Swedish Orpha...
May 10, 2023, 11:13 am
Benzene market set to reach usd 71.5 billion by 2032 | cagr of 6.2%; market.us
According to market.us’s exclusive insights, Asia Pacific leads the benzene market with a 45% revenue share, driven by growth in end-use industries ...
May 10, 2023, 10:57 am
Eton pharmaceuticals announces commercial availability of betaine anhydrous for oral solution, a generic version of cystadane® (betaine anhydrous for oral solution)
— Eton Cares patient support program offers $0 co-pay to eligible, commercially insured patients* —— Product is now available exclusively throug...
May 10, 2023, 10:50 am
Cerevel therapeutics appoints susan altschuller, ph.d. as chief financial officer
Susan Altschuller, Ph.D. brings financial management, investor relations, and business planning experience from leading ...
May 10, 2023, 10:30 am
Pieris pharmaceuticals (pirs) reports q1 loss, lags revenue estimates
Pieris pharmaceuticals (PIRS) came out with a quarterly loss of $0.18 per share versus the Zacks Consen...
May 10, 2023, 9:56 am
Reata pharma tumbles after scrapping its kidney drug as earnings come in mixed
Reata pharmaceuticals is scrapping development of a kidney disease drug and put up mixed earnings Wedne...
May 10, 2023, 9:21 am
Teva pharma crumbles after first-quarter earnings miss, flat sales
Teva pharmaceutical reported lighter-than-expected earnings for the first quarter, leading Teva stock t...
May 10, 2023, 9:15 am
Harmony biosciences to present new wakix® (pitolisant) safety and efficacy data at sleep 2023 annual meeting
Late-breaking Phase 2 proof-of-concept study in Prader-Willi syndrome accepted for poster presentation PLYMOUTH MEETING, Pa. , May 10, 2023 /PRNewswir...
May 10, 2023, 8:05 am
Cymabay therapeutics to report first quarter of 2023 financial results on monday, may 15, 2023
NEWARK, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage bio...
May 10, 2023, 8:00 am
Supernus pharmaceuticals, inc. (supn) q1 2023 earnings call transcript
Supernus pharmaceuticals, Inc. (NASDAQ:SUPN ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Co...
May 9, 2023, 9:43 pm
Supernus pharmaceuticals (supn) q1 earnings and revenues beat estimates
Supernus pharmaceuticals (SUPN) came out with quarterly earnings of $0.29 per share, beating the Zacks ...
May 9, 2023, 8:37 pm
Cue biopharma reports first quarter 2023 financial results and recent business highlights
BOSTON, May 09, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutica...
May 9, 2023, 8:35 pm
Clearside biomedical to participate in a fireside chat at the jmp securities life sciences conference
ALPHARETTA, Ga., May 09, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceuti...
May 9, 2023, 8:30 pm
Amphastar pharmaceuticals (amph) tops q1 earnings and revenue estimates
Amphastar pharmaceuticals (AMPH) came out with quarterly earnings of $0.62 per share, beating the Zacks...
May 9, 2023, 7:07 pm
Xenon pharmaceuticals (xene) reports q1 loss, lags revenue estimates
Xenon pharmaceuticals (XENE) came out with a quarterly loss of $0.63 per share versus the Zacks Consens...
May 9, 2023, 6:20 pm
Tonix pharmaceuticals announces 1-for-6.25 reverse stock split
CHATHAM, N.J., May 09, 2023 (GLOBE NEWSWIRE) — Tonix pharmaceuticals Holding Corp. (Nasdaq: TNXP) (To...
May 9, 2023, 5:00 pm
Why madrigal pharmaceuticals stock is slumping today
Madrigal pharmaceuticals stock plummeted in early-morning trading following its 2023 Q1 earnings report...
May 9, 2023, 1:54 pm
Waters (wat) q1 earnings & sales miss estimates, down y/y
Waters' (WAT) first-quarter results reflect softness in the pharmaceutical market and a slowdown in ins...
May 9, 2023, 12:13 pm
Acadia pharmaceuticals (acad) q1 earnings & sales miss estimates
Acadia pharmaceuticals (ACAD) reports weaker-than-expected first-quarter 2023 results as its earnings a...
May 9, 2023, 12:13 pm
Catalyst pharmaceuticals advances snda submission plans to increase indicated maximum dose for firdapse® from 80 mg per day to 100 mg per day
Concluded Positive FDA Type-C Meeting in Early May 2023 Company On Track to Submit an sNDA Early in the Third Quarter of 2023 CORAL GABLES, Fla., May ...
May 9, 2023, 12:03 pm